David Tully brings over 20 years of medicinal chemistry and drug discovery experience to Interline. David was previously Director of Chemistry at the Novartis Institutes for Biomedical Research (NIBR) where he led discovery chemistry research teams across multiple disease areas working on molecular glues and targeted protein degradation. He also led the antiviral medicinal chemistry efforts in the NIBR Infectious Diseases Area. David began his career in drug discovery at the Genomics Institute of the Novartis Research Foundation, where he led the medicinal chemistry efforts on a number of projects in neuroscience, metabolic, respiratory, and infectious diseases that delivered several clinical stage compounds into the Novartis pipeline. When he is not working to discover new drugs, David enjoys mountain biking, hiking, and skiing. David earned his Ph.D. in organic chemistry from the University of California, Berkeley, and a B.S. in chemistry from the University of Minnesota.
VP, Medicinal Chemistry